Back to results
US 2023/0057428 A1Published application
Coronavirus disease (covid-19) vaccine
AssigneeThomas Jefferson University
InventorsMatthias Johannes SCHNELL, Christoph WIRBLICH, Drishya KURUP
Life of this patent
Estimating the term…
Abstract
The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.
Claims24
An isolated nucleic acid encoding a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, wherein the virus is a rabies virus, a vesicular stomatitis virus (VSV), or a measles virus, and wherein the portion of the SARS-CoV-2 spike protein (S) comprises a receptor binding site of the SARS-CoV-2 spike protein (S).
(canceled)
15-21. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.